Company profile: Clever Culture Systems
1.1 - Company Overview
Company description
- Provider of intelligent image analysis solutions using artificial intelligence, including APAS Independence for automated microbial environmental monitoring with digital records, audit trails, standardized workflows and reduced human error, and MRSA and VRE Analysis Modules that automate detection on chromogenic media for efficient infection control by reporting negatives and triaging positives for review.
Products and services
- MRSA and VRE Analysis Modules: Modular software packages automating detection of MRSA and VRE colonies on chromogenic media, automatically reporting negatives and triaging positives for efficient infection control review
- APAS Independence: Industrial-grade automated system for microbial environmental monitoring that enhances data integrity and traceability via digital records and audit trails, while reducing human error and standardizing workflows
- Intelligent Image Analysis Systems: AI-driven products using artificial intelligence, enabling automated microbial environmental monitoring, colony detection on chromogenic media, digital records and audit trails, standardized workflows that reduce human error
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clever Culture Systems
Arbutus Biopharma
HQ: Canada
Website
- Description: Provider of biopharmaceutical therapies for hepatitis B virus (HBV), including Imdusiran (AB-729), a subcutaneously delivered RNAi therapeutic designed to reduce HBV viral antigens such as HBsAg, and AB-101, an oral PD-L1 inhibitor intended to reawaken HBV-specific T cells by blocking the PD-1/PD-L1 protein-protein interaction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arbutus Biopharma company profile →
BioAegis Therapeutics
HQ: United States
Website
- Description: Provider of plasma gelsolin-based therapeutics for infectious, inflammatory and degenerative diseases. Offers recombinant human plasma gelsolin (rhu-pGSN) to restore depleted levels, regulate inflammation and enhance immune response without immunosuppression; ARDS treatment; host-directed therapeutics; >40-patent IP; clinical trials and research collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAegis Therapeutics company profile →
Hygiena
HQ: United States
Website
- Description: Provider of environmental testing and sanitation products for industrial food processors, healthcare institutions, life science researchers, and the general public, including rapid hygiene monitoring systems, environmental collection systems, rapid dilution devices, ATP monitoring, real-time PCR, ELISA tests, and allergen, foodborne pathogen, and spoilage organism testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hygiena company profile →
Enochian Biopharma
HQ: United States
Website
- Description: Provider of biotechnology, operating as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enochian Biopharma company profile →
Adrenomed
HQ: Germany
Website
- Description: Provider of clinical-stage biopharmaceutical development focused on rescuing vascular integrity to save critically ill patients with limited treatment options, including the lead product candidate Adrecizumab, a first-in-class monoclonal antibody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adrenomed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clever Culture Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clever Culture Systems
2.2 - Growth funds investing in similar companies to Clever Culture Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clever Culture Systems
4.2 - Public trading comparable groups for Clever Culture Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →